Our major research programme concerns the folding, stability and activity of proteins. We apply a broad multi-disciplinary approach that combines methods and ideas of molecular biology and physical-organic chemistry. We use techniques including protein engineering, DNA cloning, sequencing and mutagenesis, cell culture, gene and peptide synthesis, spectroscopy, rapid reaction techniques, multi-dimensional NMR (we have a 500, 600, 700 and an 800 MHz spectrometers) and x-ray protein crystallography.

Current major projects include: protein folding, misfolding and disease; drug discovery; and structure-activity relationships of proteins involved in cancer and disease.

Although now emeritus, I am still fully active in research with long term funding, including an MRC Programme Grant.

Publications

Combining Simulation and Experiment to Map Protein Folding
AL Jonsson, AR Fersht, V Daggett
COMPREHENSIVE BIOPHYSICS, VOL 3: THE FOLDING OF PROTEINS AND NUCLEIC ACIDS
(2012)
3
Evaluating Drosophila p53 as a Model System for Studying Cancer Mutations
G Herzog, AC Joerger, MD Shmueli, AR Fersht, E Gazit, D Segal
The Journal of biological chemistry
(2012)
287
Chemical physics of protein folding
PG Wolynes, WA Eaton, AR Fersht
Proceedings of the National Academy of Sciences
(2012)
109
Stability of p53 Homologs
T Brandt, JL Kaar, AR Fersht, DB Veprintsev
PLoS ONE
(2012)
7
Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2
SM Vogel, MR Bauer, AC Joerger, R Wilcken, T Brandt, DB Veprintsev, TJ Rutherford, AR Fersht, FM Boeckler
Proceedings of the National Academy of Sciences of the United States of America
(2012)
109
Sequence-dependent sliding kinetics of p53
JS Leith, A Tafvizi, F Huang, WE Uspal, PS Doyle, AR Fersht, LA Mirny, AM van Oijen
Proc Natl Acad Sci U S A
(2012)
109
Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy.
M Bista, SM Freund, AR Fersht
Proceedings of the National Academy of Sciences
(2012)
109
In support of the BMRB.
JL Markley, H Akutsu, T Asakura, M Baldus, R Boelens, A Bonvin, R Kaptein, A Bax, I Bezsonova, MR Gryk, JC Hoch, DM Korzhnev, MW Maciejewski, D Case, WJ Chazin, TA Cross, S Dames, H Kessler, O Lange, T Madl, B Reif, M Sattler, D Eliezer, A Fersht, J Forman-Kay, LE Kay, J Fraser, J Gross, T Kortemme, A Sali, T Fujiwara, K Gardner, X Luo, J Rizo-Rey, M Rosen, RR Gil, C Ho, G Rule, AM Gronenborn, R Ishima, J Klein-Seetharaman, P Tang, P van der Wel, Y Xu, S Grzesiek, S Hiller, J Seelig, ED Laue, H Mott, D Nietlispach, I Barsukov, L-Y Lian, D Middleton, T Blumenschein, G Moore, I Campbell, J Schnell, IJ Vakonakis, A Watts, MR Conte, J Mason, M Pfuhl, MR Sanderson, J Craven, M Williamson, C Dominguez, G Roberts, U Günther, M Overduin, J Werner, P Williamson, C Blindauer, M Crump, P Driscoll, T Frenkiel, A Golovanov, S Matthews, J Parkinson, D Uhrin, M Williams, D Neuhaus, H Oschkinat, A Ramos, DE Shaw, C Steinbeck, M Vendruscolo, GW Vuister, KJ Walters, H Weinstein, K Wüthrich, S Yokoyama
Nature Structural Molecular Biology
(2012)
19
First-order rate-determining aggregation mechanism of p53 and its implications
G Wang, AR Fersht
Proceedings of the National Academy of Sciences
(2012)
109
Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition.
R Wilcken, G Wang, FM Boeckler, AR Fersht
Proceedings of the National Academy of Sciences
(2012)
109